Mechanical Circulatory Support in Women.

Area of Science:

• Cardiology
• Mechanical Circulatory Support
• Gender Disparities in Medicine

Background:

• Mechanical circulatory support (MCS) devices are crucial for acute cardiogenic shock (CS) and end-stage heart failure (HF).
• Women present differently than men with CS and HF, often being more critically ill upon admission.
• Existing evidence indicates women benefit equally or more than men from MCS, yet remain underrepresented in clinical trials.

Purpose of the Study:

• To review current evidence on gender differences in the use of temporary MCS for CS.
• To examine gender-specific outcomes and challenges with durable left ventricular assist devices (LVADs).
• To explore MCS application in conditions prevalent in women, such as peripartum cardiomyopathy.

Main Methods:

• Systematic review of existing literature on mechanical circulatory support in male and female patients.
• Analysis of clinical trial data and observational studies focusing on gender-specific outcomes.
• Inclusion of studies addressing MCS in conditions unique to or more common in women.

Main Results:

• Women may experience greater benefits from temporary MCS in CS related to acute myocardial infarction.
• In durable LVAD recipients, women face higher risks of thromboembolic events and right heart failure.
• Underrepresentation of women in MCS clinical trials limits comprehensive understanding.

Conclusions:

• Gender-based differences in CS and HF pathophysiology necessitate tailored MCS strategies.
• Further research is critical to optimize temporary MCS and durable LVAD therapy for women.
• Investigating MCS in female-specific cardiovascular conditions is essential for equitable care.